Stay updated on T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial

Sign up to get notified when there's something new on the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A minor platform/version indicator on the page changes from Revision: v3.5.2 to Revision: v3.5.3, with no visible update to the underlying trial record history.
    Difference
    0.1%
    Check dated 2026-04-23T21:54:11.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The study record history shows the addition of Revision: v3.5.2 and the deletion of Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T12:39:06.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision History updated to include Revision: v3.5.0 and remove Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:40:01.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added to the history, and the previous revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T17:55:05.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    A new revision entry (Revision: v3.4.2) was added to the record history, and the notice about government funding lapse as well as the previous revision (v3.4.1) were removed.
    Difference
    0.9%
    Check dated 2026-02-11T09:18:42.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Notice about government funding affecting site operations was added, and the site version was updated to v3.4.1 while v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-04T05:15:16.000Z thumbnail image

Stay in the know with updates to T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page.